In pediatric gliomas the MAPK pathway or its downstream effectors, which contribute to tumorigenesis and growth of many types of cancers, can be activated as a consequence of NF1 and BRAF gene mutations (Truong and Nicolaides, 2015; Mackay et al., 2017) In addition, BMP signaling, is also active in pediatric HGG tumor cells (Mendez et al., 2020). This evidence concerns the gene BRAF and glioma.